Walter Md Flamenbaum - Oct 13, 2021 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
/s/ Christine Klaskin, attorney-in-fact
Stock symbol
INKT
Transactions as of
Oct 13, 2021
Transactions value $
$0
Form type
3
Date filed
10/20/2021, 06:59 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 167K $0.01 Direct F1
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 139K $0.01 Direct F1
holding INKT Stock Option (Right to Buy) Oct 13, 2021 Common Stock 41.7K $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting of all such options was accelerated on March 31, 2021 and were fully-vested as of such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney